Joseph Quinn, MD, Neurology, Portland, OR, VA Portland Healthcare System

JosephFrancisQuinnMD

Neurology Portland, OR

Movement Disorder, Dementia & Geriatrics

Director of the OHSU Parkinson Center and Movement Disorder Program Director of the Portland VAMC Parkinson’s Disease Research, Education, and Clinical Center (PADRECC) Professor of Neurology, OHSU School of Medicine

Dr. Quinn is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Quinn's full profile

Already have an account?

Education & Training

  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Neurology, 1991 - 1994
  • Keck School of Medicine of USC
    Keck School of Medicine of USCClass of 1990

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1991 - 2021
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Key Role of T Cells in Parkinson's Disease Pathogenesis and Therapy  
    Joseph Quinn, MD, Parkinsonism & Related Disorders

Press Mentions

  • Parkinson’s Resources of Oregon Continues to Serve Patients
    Parkinson’s Resources of Oregon Continues to Serve PatientsMay 11, 2020 09:29
  • OHSU Drug Study in Fight Against Parkinson's Disease Shows Promise, Researchers Say
    OHSU Drug Study in Fight Against Parkinson's Disease Shows Promise, Researchers SayJuly 12, 2018 18:05
  • OHSU Looks for Parkinson's Patients to Test Drug That Could Point to Cause of Disease
    OHSU Looks for Parkinson's Patients to Test Drug That Could Point to Cause of DiseaseJune 20, 2018 18:30

Grant Support

  • Biomarkers And Genetics CoreNational Institute On Aging2010–2012
  • Removing Copper For Pennies: An Affordable Strategy For Alzheimer'SVeterans Affairs2011
  • Comprehensive Oregon Neuroscience Network For Excellence In Clinical TrialsNational Institute Of Neurological Disorders And Stroke2011
  • Effects Of Docosahexaenoic Acid (DHA) In Slowing The Progression Of AD (DHA)National Institute On Aging2006–2010
  • Copper Complexing With Tetrathiomolybdate In A Murine Model Of Alzheimers DiseaseNational Institute On Aging2007
  • Copper Complexing With Tetrahiomolybdate In A Murine Model Of Alzheimers DiseaseNational Institute On Aging2006
  • A Comparison Across Age Groups, Genotype, And Cognitive StatusNational Center For Research Resources2004–2005
  • Plasma Reliability And Saliva ValidityNational Center For Research Resources2004

Professional Memberships

Hospital Affiliations